Skip to Main Content
Wyss Institute
Menu
Search Site
Who We Are
About
Team
Careers
Contact
Our Model
How We Work
Collaboration
Our Work
Technologies
Impact Report
Business Insider
Publications
Newsroom
News
Press Resources
Multimedia
Events
Give
Search
View our 2023 Impact Report
Search results
13 Results for 'Gene Regulation'
Technologies
(1)
Collaborations
(0)
Team
(0)
News
(11)
Pages
(0)
Multimedia
(1)
Publications
(0)
Jobs
(0)
Events
(0)
Technologies
1
CogniXense: A Platform for Rapid Drug Repurposing
CogniXense is a target-agnostic drug discovery platform that enables the repurposing of drugs for rare genetic diseases in record time. By combining human data-based computational drug prediction with on-demand animal model development, we can mimic the diversity of symptoms of patient populations and begin drug screening on new diseases within a month.
News
11
View all
Community
How tadpoles can help cure rare genetic diseases
October 20, 2020
Press Release
A reliable clock for your microbiome
October 11, 2019
Research Spotlights
Light shed on century-old riddle of chromosome pairing
October 4, 2019
Multimedia
1
Video/Animation
CogniXense: Speeding Up Treatments for Rare Diseases
At the Wyss Institute, we are tackling Rett syndrome, a rare disease that affects 1 out of 9,000 children, by developing a scalable model for neurodevelopmental and cognitive diseases. This model can test drugs to see which will improve memory, learning, and behavior, with the end goal of finding effective therapies. Credit: Wyss Institute at...
Close search results
close menu
Who We Are
About
Team
Careers
Contact
Our Model
How We Work
Collaboration
Our Work
Technologies
Impact Report
Business Insider
Publications
Newsroom
News
Press Resources
Multimedia
Events
Give
Close menu